Interní Med. 2015; 17(1): 14-17

Prebiotics, probiotics and intestinal microflora

prof.MUDr.Milan Lukáš, CSc.Klinické a výzkumné centrum střevních zánětů, ISCARE I.V.F.as Lighthouse, Praha
Ústav biochemie a laboratorní diagnostiky 1. LF UK, Praha

The intestinal microbiota are forming the special system in the human body, whose composition and function has been recognized only

partially. Probiotics are living micro-organisms of the human originate, who are supporting for human health. The intestinal microbiota

change, which are induced due to antibiotics therapy, dietary change and a new preparation of meal can participate in arising incidence of

autoimmune mediated disease, like as inflammatory bowel diseases, celiac disease and various type of allergic reaction.The most utilizing

in clinical practic today are: Escherichia coli strain Nissle 1917, Lactobacilus rhamnosus, Lactobacilus rutei and Saccharomyces boulardii.

Keywords: probiotics, prebiotics,intestinal microbiota. Interní Med. 2015; 17(1): 14–17

Published: February 27, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lukáš M, výzkumné centrum střevních zánětů KA, ISCARE as Lighthouse IVF, Praha. Prebiotics, probiotics and intestinal microflora. Interní Med. 2015;17(1):14-17.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lukáš M. Mutaflor - Escherichia coli kmen Nissle 1917, sérotyp 06:K5:H1 Gastroent Hepatol 2013; 67(2): 170-171.
    2. Bousvaros A, Lee JW. Efficacy of probiotics use in acute diarrhoea in children: a meta-analysis. Dig Dis Sci 2002; 47: 2625-2634. Go to original source... Go to PubMed...
    3. Rosenfeld V, Michaelsen KF, Jakobsen M, et al. Effect of probiotic Lactobacilus strains in children hospitalized with acute diarrrhea. Pediatr Infect Dis J, 21, 2002: 411-416. Go to original source...
    4. Elmer QW, McFarland LV. In the treatment of infectious diarrhoea. In: Infectious Diarrhoea. Gastroenterology Clinics of North America:, 3,30 September 2001, Edited by: Christina M. Surawicz. Go to PubMed...
    5. Fedorak RN, Madsen KL. Probiotics and prebiotics in gastrointestinal disorders. Current Opinion in Gastroenterology 2004; 20: 146-155. Go to original source... Go to PubMed...
    6. Frič P. Probiotics in Gastroenterology. Zeitschrift fur Gastroenterologie 2002; 40: 197-201. Go to original source... Go to PubMed...
    7. Cukrowska B, Lodínová-Žádníková R, Enders C, et al. Specific proliferative and antibody responses of premature infants to intestinal colonization with non-pathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol 2002; 55: 204-209. Go to original source...
    8. Kollaratitsh H, Holst H, Grobara P, et al. Prevention of traveler's diarrhoea with Saccharomyces boulardii: Results of placebo controlled double-blind study. Fortschr Med 1993; 111: 152-156. Go to PubMed...
    9. Pelech T, Frič P, Fixa B, et al. Srovnání Mutafloru a mesalazinu v udržovací léčbě neaktivní idiopatické proktokolitidy. Prakt Lékař, 78, 1998.
    10. Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet 1999; 354: 635-639. Go to original source... Go to PubMed...
    11. Kruis W, Frič P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 2004; 53: 1617-1623. Go to original source... Go to PubMed...
    12. Pantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut2002; 52: 405-409. Go to original source...
    13. Gionchetti P, Rozeolo F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-1209. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.